MENU
+Compare
IDXG
Stock ticker: OTC
AS OF
Aug 1 closing price
Price
$0.83
Change
-$0.03 (-3.49%)
Capitalization
8.62M

IDXG Interpace Biosciences, Inc. Forecast, Technical & Fundamental Analysis

Interpace Biosciences Inc provides esoteric molecular diagnostic testing and pathology services to aid physicians in evaluating cancer risk in patients with indeterminate biopsies and a perceived high risk of cancer based on clinical features... Show more

IDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IDXG with price predictions
Aug 01, 2025

IDXG's RSI Oscillator leaves overbought zone

The 10-day RSI Oscillator for IDXG moved out of overbought territory on July 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on IDXG as a result. In of 128 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for IDXG turned negative on July 30, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IDXG declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IDXG broke above its upper Bollinger Band on July 14, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

IDXG moved above its 50-day moving average on July 08, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IDXG crossed bullishly above the 50-day moving average on July 14, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where IDXG advanced for three days, in of 175 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 116 cases where IDXG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.533). P/E Ratio (0.000) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.244) is also within normal values, averaging (43.112).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IDXG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IDXG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
IDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IDXG is expected to report earnings to fall 191.67% to 10 cents per share on March 07

Interpace Biosciences, Inc. IDXG Stock Earnings Reports
Q4'23
Est.
$0.11
Q3'23
Missed
by $0.11
Q2'23
Beat
by $0.17
Q1'23
Beat
by $0.29
Q4'22
Missed
by $0.26
The last earnings report on November 08 showed earnings per share of -11 cents, missing the estimate of 0 cents. With 8.72K shares outstanding, the current market capitalization sits at 8.62M.
A.I. Advisor
published General Information

General Information

a provider of commercialization services to biopharmaceutical companies

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
300 Interpace Parkway
Phone
+1 855 776-6419
Employees
94
Web
https://www.interpace.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ADC73.732.03
+2.83%
Agree Realty Corp
CB267.401.36
+0.51%
Chubb Limited
CCG0.76N/A
+0.04%
Cheche Group
APOG40.40-1.59
-3.79%
Apogee Enterprises
CREX2.60-0.12
-4.41%
Creative Realities

IDXG and Stocks

Correlation & Price change

A.I.dvisor tells us that IDXG and SNWV have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IDXG and SNWV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXG
1D Price
Change %
IDXG100%
-3.49%
SNWV - IDXG
20%
Poorly correlated
-5.80%
IMDX - IDXG
5%
Poorly correlated
+1.59%
SSKN - IDXG
2%
Poorly correlated
N/A
SENS - IDXG
2%
Poorly correlated
+0.78%
PLSE - IDXG
-0%
Poorly correlated
+0.14%
More